<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Baseline demographics and disease characteristics</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>Patients (
     <italic>n</italic> = 49)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Age, (years)</td>
    <td>65 (27–86)</td>
   </tr>
   <tr>
    <td colspan="2">Sex</td>
   </tr>
   <tr>
    <td> Men</td>
    <td>32 (65.3)</td>
   </tr>
   <tr>
    <td> Women</td>
    <td>17 (34.7)</td>
   </tr>
   <tr>
    <td colspan="2">Histology</td>
   </tr>
   <tr>
    <td> Diffuse large B-cell lymphoma (DLBCL)</td>
    <td>24 (49.0)</td>
   </tr>
   <tr>
    <td> Follicular lymphoma (FL)</td>
    <td>14 (28.6)</td>
   </tr>
   <tr>
    <td> Mantle cell lymphoma (MCL)</td>
    <td>7 (14.3)</td>
   </tr>
   <tr>
    <td> Marginal zone lymphoma (MZL)</td>
    <td>4 (8.2)</td>
   </tr>
   <tr>
    <td colspan="2">Disease stage at study entry</td>
   </tr>
   <tr>
    <td> I</td>
    <td>2 (4.1)</td>
   </tr>
   <tr>
    <td> II</td>
    <td>5 (10.2)</td>
   </tr>
   <tr>
    <td> III</td>
    <td>16 (32.7)</td>
   </tr>
   <tr>
    <td> IV</td>
    <td>26 (53.1)</td>
   </tr>
   <tr>
    <td colspan="2">Number of prior systemic therapies</td>
   </tr>
   <tr>
    <td> 1</td>
    <td>5 (10.2)</td>
   </tr>
   <tr>
    <td> 2</td>
    <td>9 (18.4)</td>
   </tr>
   <tr>
    <td>  ≥ 3</td>
    <td>35 (71.4)</td>
   </tr>
   <tr>
    <td> Median</td>
    <td>3 (1–13)</td>
   </tr>
   <tr>
    <td>Previous radiotherapy</td>
    <td>15 (30.6)</td>
   </tr>
   <tr>
    <td>Previous autologous transplant</td>
    <td>16 (32.7)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Data are median (range) or n (%)</p>
 </table-wrap-foot>
</table-wrap>
